INDV Stock Analysis: Buy, Sell, or Hold?
INDV - Indivior PLC Ordinary Shares
$35.38
0.67 (1.93%)
▲
BUY
MODERATE Confidence
Last Updated: January 30, 2026
Earnings: Feb 26, 2026
24d
Get Alerted When INDV Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: INDV shows positive signals but monitor for confirmation. Market pricing in 0.2% annual growth which appears achievable. Moderate conviction.
💡 BUY OPPORTUNITY: INDV shows positive signals but monitor for confirmation. Market pricing in 0.2% annual growth which appears achievable. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$68.64
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$42.62
17.0% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 11.8x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: INDV is currently trading at $35.38, which is considered fair relative to its 30-day fair value range of $33.59 to $36.14. The stock's valuation (Forward PE: 11.8) is in line with its historical norms (11.8). At these levels, the market is pricing in 0.2% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, INDV is in a strong uptrend. The price is approaching resistance at $35.47. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $45.57 (+28.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, INDV is in a strong uptrend. The price is approaching resistance at $35.47. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $45.57 (+28.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Fair Price Range
$33.59 -
$36.14
Company Quality Score
60/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
73.3%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 28.8% below Wall St target ($45.57)
- NEUTRAL: Market pricing in 0.2% annual earnings growth - fairly valued
Fair Price Analysis
30-Day Fair Range
$33.59 -
$36.14
Current vs Fair Value
FAIR
Support & Resistance Levels
Support Level
$31.70
Resistance Level
$35.47
Current Trend
Strong Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
11.84
Wall Street Target
$45.57
(+28.8%)
Revenue Growth (YoY)
2.3%
Earnings Growth (YoY)
106.3%
Profit Margin
10.5%
Valuation Premium vs History
+0.2% premium
PE vs Historical
11.8 vs 11.8
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+0.2%
(market-implied from PE analysis)
1-Year Target
$35.45
(+0%)
2-Year Target
$35.52
(+0%)
3-Year Target
$35.59
(+1%)
3-Yr Target (if PE normalizes)
(PE: 12→12)
PE COMPRESSION
$35.46
(+0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.3, Growth: 28.0%)
$139.83
(+295%)
Base:
(SPY PE: 11.8, Growth: 28.0%)
$74.27
(+110%)
Bear:
(PE: 10.1, Growth: 28.0%)
$63.13
(+78%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (36x PE), but valuation improves significantly next year (12x PE) as earnings recover.
Trailing PE: 35.64 | Current EPS (TTM): $0.98
Bull Case
$76.85
(+117%)
Analyst growth 100.0%, PE expands to 39.2
Base Case
$69.86
(+98%)
Market implied 100.0%, PE stable at 35.6
Bear Case
$23.75
(-33%)
Severe decline -20.0%, PE contracts to 30.3
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Last updated: February 01, 2026 6:34 AM ET
Data refreshes hourly during market hours. Next update: 7:34 AM
Data refreshes hourly during market hours. Next update: 7:34 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is INDV showing a specific setup today?
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
25 analysts |
$179 | 62 BUY |
|
ZTS
Zoetis Inc |
STRONG BUY
19 analysts |
$158 | 56 HOLD |
|
LNTH
Lantheus Holdings Inc |
STRONG BUY
13 analysts |
$84 | 57 HOLD |
|
BCRX
BioCryst Pharmaceuticals… |
STRONG BUY
12 analysts |
$21 | 55 HOLD |
|
HCM
HUTCHMED DRC |
STRONG BUY
14 analysts |
$21 | 57 HOLD |
Advanced INDV Option Strategies
Professional options setups generated by AI based on today's INDV price and gamma walls.
